Jose Miguel Pérez Villares
Jose Miguel Pérez Villares has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Domínguez-Gil
Organización Nacional de Trasplantes, Madrid, Spain
2 shared publications A. Osuna Ortega
Servicio de Nefrología, Hospital Universitario Virgen de las Nieves, Granada, España
1 shared publication- Alicia Pérez-Blanco
Organización Nacional de Trasplantes, Madrid, Spain
1 shared publication Antonia José Álvarez-Márquez
Coordinación Autonómica de Trasplantes de Andalucía, Servicio Andaluz de Salud, Sevilla, Spain
1 shared publicationConcepción Díaz-Aunión
Coordinación Autonómica de Trasplantes de Andalucía, Servicio Andaluz de Salud, Sevilla, Spain
1 shared publication- D. Daga Ruiz
Coordinación Autonómica de Trasplantes de Andalucía, Servicio Andaluz de Salud, Hospitales Universitarios: Regional de Málaga, Virgen de las Nieves de Granada y Virgen del Rocío de Sevilla, Málaga, España
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 449
Letter to the Editor: “Organ donation after ECPR: ethical challenges and clinical implications”
- 27 August 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 449
Open AccessLetter to the Editor: “Organ donation after ECPR: ethical challenges and clinical implications”
- Open Access
Family bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol
Introduction There is a discrepancy in the literature as to whether authorising or refusing the recovery of organs for transplantation is of direct benefit to families in their subsequent grieving process. This study aims to explore the impact of the family interview to pose the option of posthumous donation and the decision to authorise or refuse organ recovery on the grieving process of potential donors’ relatives. Methods and analysis A protocol for mixed methods, prospective cohort longitudinal study is proposed. Researchers do not randomly assign participants to groups. Instead, participants are considered to belong to one of three groups based on factors related to their experiences at the hospital. In this regard, families in G1, G2 and G3 would be those who authorised organ donation, declined organ donation or were not asked about organ donation, respectively. Their grieving process is monitored at three points in time: 1 month after the patient’s death, when a semistructured interview focused on the lived experience during the donation process is carried out, 3 months and 9 months after the death. At the second and third time points, relatives’ grieving process is assessed using six psychometric tests: State-Trait Anxiety Inventory, Beck Depression Inventory-II, Inventory of Complicated Grief, The Impact of Event Scale: Revised, Posttraumatic Growth Inventory and Connor-Davidson Resilience Scale. Descriptive statistics (means, SDs and frequencies) are computed for each group and time point. Through a series of regression models, differences between groups in the evolution of bereavement are estimated. Additionally, qualitative analyses of the semistructured interviews are conducted using the ATLAS.ti software. Ethics and dissemination This study involves human participants and was approved by Comité Coordinador de Ética de la Investigación Biomédica de Andalucía (CCEIBA) ID:1052-N-21. The results will be disseminated at congresses and ordinary academic forums. Participants gave informed consent to participate in the study before taking part.
Open AccessFamily bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol
Introduction There is a discrepancy in the literature as to whether authorising or refusing the recovery of organs for transplantation is of direct benefit to families in their subsequent grieving process. This study aims to explore the impact of the family interview to pose the option of posthumous donation and the decision to authorise or refuse organ recovery on the grieving process of potential donors’ relatives. Methods and analysis A protocol for mixed methods, prospective cohort longitudinal study is proposed. Researchers do not randomly assign participants to groups. Instead, participants are considered to belong to one of three groups based on factors related to their experiences at the hospital. In this regard, families in G1, G2 and G3 would be those who authorised organ donation, declined organ donation or were not asked about organ donation, respectively. Their grieving process is monitored at three points in time: 1 month after the patient’s death, when a semistructured interview focused on the lived experience during the donation process is carried out, 3 months and 9 months after the death. At the second and third time points, relatives’ grieving process is assessed using six psychometric tests: State-Trait Anxiety Inventory, Beck Depression Inventory-II, Inventory of Complicated Grief, The Impact of Event Scale: Revised, Posttraumatic Growth Inventory and Connor-Davidson Resilience Scale. Descriptive statistics (means, SDs and frequencies) are computed for each group and time point. Through a series of regression models, differences between groups in the evolution of bereavement are estimated. Additionally, qualitative analyses of the semistructured interviews are conducted using the ATLAS.ti software. Ethics and dissemination This study involves human participants and was approved by Comité Coordinador de Ética de la Investigación Biomédica de Andalucía (CCEIBA) ID:1052-N-21. The results will be disseminated at congresses and ordinary academic forums. Participants gave informed consent to participate in the study before taking part.
- Open Access
- 1 December 2020
- Published by Elsevier in Cytotherapy
- Vol. 22 (12) , 712-717
Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine
- 1 December 2020
- Published by Elsevier in Cytotherapy
- Vol. 22 (12) , 712-717
Open AccessPromoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine
- 1 January 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (1) , 59-60
El derecho a ser donante de órganos y tejidos al final de la vida del paciente crítico
- 1 January 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (1) , 59-60
El derecho a ser donante de órganos y tejidos al final de la vida del paciente crítico
- 1 May 2013
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 37 (4) , 224-231
Código alfa. Inicio de un nuevo programa de donación en asistolia
- 1 May 2013
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 37 (4) , 224-231
Código alfa. Inicio de un nuevo programa de donación en asistolia